Corporate Breaking News
Corporate Breaking News
Home : Amgen Provides Updated Information On LUMAKRAS™ (Sotorasib)¹ Dose Comparison Study
Apr 28
2021

Amgen Provides Updated Information On LUMAKRAS™ (Sotorasib)¹ Dose Comparison Study

THOUSAND OAKS, Calif., April 28, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it agreed last night with the FDA's proposed post-marketing requirement to conduct, as part of the ongoing development program, a multi-center randomized clinical trial to compare the safety and...
Source:https://www.prnewswire.com:443/news-releases/amgen-provides-updated-information-on-lumakras-sotorasib-dose-comparison-study-301278732.html
 
Related News
» Four CKGSB Professors Named as Highly Cited Chinese Researchers of 2020 by Elsevier
» Singapore International Energy Week 2021 Brings Global Leaders Together to Advance the Energy Transition
Home
About us
Archive
Sitemap
Powered By Corporate Breaking News.com Home| About us| Archive News| Sitemap